CONSULTING AGREEMENTConsulting Agreement • March 30th, 2006 • Elan Corp PLC • Pharmaceutical preparations • California
This Consulting Agreement (the “Agreement”) is made by and between Dennis J. Selkoe, M.D., an individual with an address of Center for Neurologic Diseases, Harvard Medical School, Brigham and Women’s Hospital, 221 Longwood Avenue-LMRC, Boston, MA 02115 (“Consultant”), and Elan Pharmaceuticals, Inc., a Delaware corporation with an address of 800 Gateway Boulevard, South San Francisco, California 94080 (“Elan”), and is effective as of May 20, 2004 (“Effective Date”).
FIRST SUPPLEMENTAL INDENTURE Dated as of October 28, 2005 to INDENTURE Dated as of November 10, 2003 among ELAN CAPITAL CORP., LTD., as Issuer, ELAN CORPORATION, PLC, as Guarantor, and THE BANK OF NEW YORK, as TrusteeSupplemental Indenture • March 30th, 2006 • Elan Corp PLC • Pharmaceutical preparations • New York
FIRST SUPPLEMENTAL INDENTURE, dated as of October 28, 2005 (the “Supplemental Indenture”), to the Indenture, dated as of November 10, 2003 (the “Existing Indenture” and, as supplemented by this Supplemental Indenture, the “Indenture”), among ELAN CAPITAL CORP., LTD., a Bermuda exempted company limited by shares (hereinafter called the “Company”), ELAN CORPORATION, PLC, a public limited liability company organized under the laws of Ireland (hereinafter called the “Guarantor”), and THE BANK OF NEW YORK, a New York banking corporation, as trustee (the “Trustee”).
